Branded drugs boost Teva revenue
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported its second quarter 2026 financial results. The Israeli drugmaker ...
Wednesday, August 5, 2026
Tag: Teva
Teva stocks downward trend continues
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended the trading week on Wall Street down 2.8% with falls ...
Teva reports positive skin treatment drug results
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has reported positive results for TEV-’408, an investigational anti-interleukin-15 monoclonal antibody, ...
Teva to lay off 250 in API division in Israel
Teva had been in talks to sell its active pharmaceutical ingredients activity but a deal never materialized. ...
Teva acquires Emalex Biosciences for up to $900m
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...
Teva Pharmaceuticals – TEVA: Abschied vom Generika-Geschäft! Was nun?
Strategische Neuausrichtung! Pullback-Setup bei der Teva-Aktie! Kommt der Bounce nach 7 roten Kerzen? Quartalszahlen erst im Mai! Teva Pharmaceuticals (TEVA) ...
Teva sees lower revenue and profit in 2026
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended 2025 with revenue of $17.3 billion, up 4% from $16.5 ...
Teva collaborates on skin disease treatment, releases targets
Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) published two positive announcements yesterday. The first concerns collaboration with Royalty Pharma ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.